[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
Purchase Options:
[Skip to Content Landing]
Views 1,431
Citations 0
Correction
May 1, 2018

Incorrect Spelling of an Author’s Name and Data Error

JAMA. 2018;319(17):1824. doi:10.1001/jama.2018.3431

In the article entitled “Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial”1 published in the December 19, 2017, issue of JAMA, an author’s name was spelled incorrectly (Jordi Bruna, MD) in the author list and a data error occurred in Table 2, in the between-group difference and confidence intervals for the year-1 survival. This article was corrected online.

References
1.
Stupp  R, Taillibert  S, Kanner  A,  et al.  Effect of tumor-treating fields plus maintenance temozolomide vs maintenance temozolomide alone on survival in patients with glioblastoma: a randomized clinical trial.  JAMA. 2017;318(23):2306-2316.PubMedGoogle ScholarCrossref
×